Clinical Trial Update: Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated three dosing schedules of low-dose decitabine in patients with myelodysplastic syndrome and chronic myelomonocytic leukemia; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2011-05-26